Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the ‘ASsessment in AS’ international working group …

Objectives. Although clinicians recognize hip involvement, which frequently leads to hip
replacement surgery, as an important feature of AS, data on the epidemiology, nature of the …

Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …

Objective To investigate the efficacy and safety of ixekizumab in patients with active radiographic
axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of 1 or 2 …

Objectives To create a model that provides a potential basis for candidate selection for anti-tumour
necrosis factor (TNF) treatment by predicting future outcomes relative to the current …

Background Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and active …

Familial Mediterranean fever (FMF), a recessively inherited autoinflammatory disorder, is
the prototype of a group of disorders termed systemic autoinflammatory diseases. Such …

Objective To assess HLA-B27 influence on the clinical phenotype of Ankylosing Spondylitis (AS)
patients. Method An observational, cross-sectional and descriptive study of AS patients …

Objective: To evaluate the long-term safety and efficacy of adalimumab in patients with
ankylosing spondylitis (AS) and total spinal ankylosis (TSA). Design: Patients (n = 315) with …

… Estefania Moreno, Anna Fagil, and Iñaki Galache (Hospital San Rafael, Barcelona); Eduardo
Collantes Estévez, María Dolores Miranda García, Desirée Ruiz Vílchez, Manuel Arias López …